Efficacy of Bortezomib as an Adjunctive Therapy for Refractory Chronic Active Antibody-Mediated Rejection in Kidney Transplant Patients: A Single-Center Experience
| Autor: | Larpparisuth, Nuttasith, Skulratanasak, Peenida, Premasathian, Nalinee, Vongwiwatana, Attapong |
|---|---|
| Zdroj: | In Transplantation Proceedings December 2019 51(10):3293-3296 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect